Skip to main content

Table 2 Utilities for each visual acuity state

From: Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema

Visual acuity

Time trade-off

Standard gamble

> 20/40

0.85 (0.75–0.95)

0.90 (0.83–0.97)

≤ 20/40 to > 20/80

0.78 (0.72–0.84)

0.92 (0.88–0.96)

≤ 20/80 to > 20/200

0.78 (0.67–0.89)

0.84 (0.72–0.96)

≤ 20/200 to > 20/400

0.64 (0.53–0.75)

0.71 (0.58–0.84)

≤ 20/400

0.59 (0.23–0.95)

0.70 (0.29–1.11)

  1. Utilities according to visual acuity in the better-seeing eye obtained in a cohort of patients with DME [16]